Navigation Links
New Research Suggests Platelet 'Stickiness' May be the Single Most Important Risk Factor in Patients Treated with Coronary Stents - Findings May be Applicable to Anyone with Vascular Disease
Date:1/27/2009

BALTIMORE, Jan. 27 /PRNewswire/ -- Most Americans know their cholesterol level, but do they know how "sticky" their platelets are? Research findings from Dr. Paul A. Gurbel, an interventional cardiologist and Director of the Sinai Center for Thrombosis Research based at Sinai Hospital of Baltimore, indicate that platelet aggregation or "stickiness" may be the single largest factor in determining the likelihood of developing serious complications, including heart attack, in patients treated with coronary artery stents.

"We currently measure the cholesterol level in everyone with vascular disease, yet the pivotal event that kills the patient - platelet aggregation isn't being assessed in any way," said Dr. Gurbel.

Dr. Gurbel's findings may explain why someone with no cardiac history could die suddenly of a massive heart attack, while an individual with high blood pressure, high cholesterol and plaque-filled arteries may never have a cardiac event because they had low platelet aggregation.

Along with his team at Sinai, Dr. Gurbel demonstrated that patients with platelets most prone to aggregate had the highest prevalence of complications, including heart attack, after coronary artery stenting.

Their work is helping to revolutionize the testing and treatment of patients with coronary artery disease, offering further evidence that a more personalized approach to anti-platelet therapy needs to be established.

Dr. Gurbel was one of the first researchers in the world to discover that up to 30% of patients taking clopidogrel, a drug designed to decrease platelet aggregation, do not respond to treatment.

"Of the millions of cardiac patients treated with clopidogrel, a significant percentage are non-responsive and remain at high risk for a major cardiac event," said Dr. Gurbel. "The platelet aggregation of each patient needs to be precisely measured to determine
'/>"/>

SOURCE Sinai Hospital of Baltimore
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Why Wait for an Anti-Aging Drug? Researchers Interviewed on CBS-TVs 60 MINUTES Discover Longevinex(R) Nutriceutical Matrix Activates 9-Fold More Longevity Genes than Plain Resveratrol
2. Phidea Srl and Marvin Research Srl Announce Completion of Merger
3. Stents Can Treat - Not Just Prevent - Strokes, Suggests Early Research
4. Inclinix Releases Next Generation Critical Population Research(R) (CPR) for Clinical Trial Investigator Site Selection and Patient Recruitment
5. Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University
6. WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System
7. Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinsons Disease Research
8. Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF
9. 2008 Human Research Protection Award Recipients Announced
10. New Research Reveals Unforeseen Side Effect of the Breast Cancer Movement
11. K-State Researcher Finds Correlation Between Childhood Obesity and Asthma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...K,Calif.,Nov.25/PRNewswire/--PraxisElectronicMedic...ademyofFamilyPhysicians,(AAFP)FamilyPracticeManage...medicalquality,healthmaintenance,anddiseasemanagem...salsoranked#1amongdoctorsindicatingtheirEMRhadapos...alsorankednumberoneinthecountryinprovidingexcellen...
(Date:11/25/2009)...HIA,Nov.25/PRNewswire-FirstCall/--ERT(Nasdaq: ERES...ny,sPresidentandCEO,andKeithSchneck,theCompany,sEx...the21stAnnualPiperJaffrayHealthCareConferenceat1:3... Interestedpartiesmayaccessthepresentationbyvisiti...m .Thewebcastmayalsobeaccessedat http://www.corpor...
(Date:11/25/2009)...RK,Md.,Nov.25/PRNewswire-USNewswire/--RemediumTech...oamthatstopsseverebleeding,wonfirstprizeand$10,000...ecurityChallenge2009,companyofficialsannouncetoday...eworld,Remedium,steampitchedtheirinventionattheGSC...iness. ,, Remedium( www.remediumtechnologies.co...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Key to evolutionary fitness 3A Cut the calories 9078 1Key to evolutionary fitness 3A Cut the calories 9078 2First step to converting solar energy using artificial leaf 12859 1First step to converting solar energy using artificial leaf 12859 2Specialized California Medical Center 28Heart411 com 29 Offers Top Notch Cardiothoracic Surgery 50474 1Specialized California Medical Center 28Heart411 com 29 Offers Top Notch Cardiothoracic Surgery 50474 2
... Md., April 27 As body mass increases, so does ... according to Baltimore researchers. A new study, ...f the American Urological Association (AUA), asses...luated insurance claims of 95,962 subjects over a ...ify whether obesity is associated with a UTI diagn...
... Build on Pivotal Phase III Study for the Treatmen...., April 27 Ferring Pharmaceuticals announced tod...garelix for injection, a new injectable gonadotrop...proved by the U.S. Food and Drug Administration (F...d prostate cancer. The announcement was made at...
Other Medicine Technology:Obesity Associated With Higher Risk for Urinary Tract Infections 2Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 2Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 3Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 4Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 5
(Date:11/26/2009)...25 years, the number of Americans living with diab...ion in 2009 to 44.1 million in 2034. Over the same...rising from $113 billion to $336 billion, even wit...chers based at the University of Chicago report in...mber of those with diabetes covered by Medicare wi...
(Date:11/26/2009)...ger thrill when on an emotional rollercoaster, stu...y News) -- Call it the fear factor meets the jubil...ctators -- especially those who root for the winni... a closely contested match and victory was in doub..., Chew on that this Thanksgiving weekend as you,...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a...rolina, today announced the expansion of its servi...entist, Dr. Doug Macmillan. , ...ntal is pleased to announce that Dr. Doug Macmilla...mpleted an additional advanced training seminar. ...
(Date:11/25/2009)...Minn.,Nov.25/PRNewswire-USNewswire/--Whenmostpeopl...ropractorcanalsogivepatientsthehelptheyneed.TMJsta...jaw(mandible)contacts/connectswithyourskull(tempor...TMJdysfunctionarepainwithchewing,clickingorpopping...functionincluding:headaches,fatigue,sleepdisturban...
(Date:11/25/2009)...OandCALGARY,Nov.25/PRNewswire/-SentinelleMedicalIn...MRI)coilsandsoftwareandCalgaryScientificInc.,alead...oducedawebversionofAegis(TM)Breast4DAdvancedVisual...efirsttrulyzero-footprintWebclientbasedmedicalimag...TM)platformallowsforzero-footprintaccess-requiring...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...ns of deep concern and disappointment about report...orward without addressing several issues that are ...ies were sent today to congressional leaders by th... and medical student members of ACP. , Dr. Dale t...
... 20, 2007) A Jekyll-Hyde mechanism that both prot...be the basis for new cancer-fighting drugs. , Sci...n Lindquist have discovered that a certain transcr...s the survival of cancer cells. , According to t...
...ose research is challenging conventional thinking ...fit cardiac patients, has secured funding to furth...from the Universitys Faculty of Biological Science...For a long time the cardiovascular benefits of sta...
...he job the agency is doing , , THURSDAY, ...Americans depend on prescription medicines for hea...nt,s role in keeping those medicines safe, a new s...ged the agency,s performance as poor. , "The Ameri...
... Developments in Solid Organ Transplantation, DAL...w",is the focus of a one-day meeting scheduled for...exas. Co-sponsored by the American Society of,Tran...ents in solid organ transplantation medicine and h...
...Enables Health Care Providers to Increase ...s, SAN ANTONIO, Sept. 20 AT&T Inc. (NYSE: T ),t...folio of radio frequency,identification (RFID) tra...AT&T is the first network services company to prov...
Other Medicine News:Health News:'Deep concern and disappointment' with exclusion of Medicare from SCHIP legislation 2Health News:'Deep concern and disappointment' with exclusion of Medicare from SCHIP legislation 3Health News:Heat shock proteins are co-opted for cancer 2Health News:Research to shed new light on how statins benefit heart patients 2Health News:Americans Confused About FDA and Drug Safety 2Health News:Americans Confused About FDA and Drug Safety 3Health News:Americans Confused About FDA and Drug Safety 4Health News:Dallas-Area Transplant Meeting Puts Spotlight on Key Issues 2Health News:AT&T Offers 'Network Industry-First' RFID Solution for Health Care Organizations 2Health News:AT&T Offers 'Network Industry-First' RFID Solution for Health Care Organizations 3
...Mist™ HME product line has the right product... and from intubated patients to patients with trac...ation for both anesthesia and critical care applic...de maximum protection for patients and staff membe...
...Mist™ HME product line has the right product... and from intubated patients to patients with trac...ation for both anesthesia and critical care applic...de maximum protection for patients and staff membe...
...Mist™ HME product line has the right product... and from intubated patients to patients with trac...ation for both anesthesia and critical care applic...de maximum protection for patients and staff membe...
...roscopic condenser humidifiers (HCH) capture the p... in the inspired gas. Small and compact, they are ...groscopic benefits. Depending on the tidal volume ...ume model., ,The adult HCH is ideal for patient t...
Medicine Products: